Met and HGF inhibition in triple-negative breast cancer cell lines

被引：0
|
作者：
Gaule, Patricia Brid
Collins, Denis
Walsh, Naomi
Duffy, Michael J.
Crown, John
O'Donovan, Norma
机构：
[1] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland
[2] St Vincents Univ Hosp, Clin Res Ctr, Dublin 4, Ireland
[3] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland
[4] Dublin City Univ, Dublin 9, Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1066
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines
    Taurin, Sebastien
    Rosengren, Rhonda J.
    MEDICAL ONCOLOGY, 2022, 40 (01)
  • [2] Bosutinib Reduces the Efficacy of Dasatinib in Triple-negative Breast Cancer Cell Lines
    Tarpley, Mike
    Abdissa, Temesgen T.
    Johnson, Gary L.
    Scott, John E.
    ANTICANCER RESEARCH, 2014, 34 (04) : 1629 - 1635
  • [3] Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines
    Sebastien Taurin
    Rhonda J. Rosengren
    Medical Oncology, 40
  • [4] Role of mTOR inhibition in triple-negative breast cancer
    Massihnia, Daniela
    Bronte, Giuseppe
    Castiglia, Marta
    Barraco, Nadia
    Cangemi, Antonina
    Perez, Alessandro
    Fanale, Daniele
    Pantuso, Gianni
    Vieni, Salvatore
    Calo, Valentina
    Rolfo, Christian D.
    Bazan, Viviana
    Russo, Antonio
    CANCER RESEARCH, 2016, 76
  • [5] Lipogenesis inhibition in triple-negative breast cancer (TNBC)
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Polonio, Emma
    Ciurana, Joaquim
    Vinas, Gemma
    Puig, Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S58 - S58
  • [6] The Wnt3a targetome in triple-negative breast cancer cell lines
    Maubant, Sylvie
    Tesson, Bruno
    Maire, Virginie
    Ye, Mengliang
    Rigaill, Guillem
    Gentien, David
    Cruzalegui, Francisco
    Tucker, Gordon C.
    Roman-Roman, Sergio
    Dubois, Thierry
    CANCER RESEARCH, 2015, 75
  • [7] Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells
    Gaule, Patricia
    Mukherjee, Nupur
    Corkery, Brendan
    Eustace, Alex J.
    Gately, Kathy
    Roche, Sandra
    O'Connor, Robert
    O'Byrne, Kenneth J.
    Walsh, Naomi
    Duffy, Michael J.
    Crown, John
    O'Donovan, Norma
    CANCERS, 2019, 11 (04):
  • [8] Triple-negative breast cancer
    Bartsch R.
    Ziebermayr R.
    Zielinski C.C.
    Steger G.G.
    Wiener Medizinische Wochenschrift, 2010, 160 (7-8) : 174 - 181
  • [9] Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines
    Ku, Ja-Lok
    Park, Sung-Chan
    Kim, Kyung-Hee
    Jeon, You-Kyung
    Kim, Sung-Hee
    Shin, Young-Kyoung
    Noh, Dong-Young
    Im, Seock-Ah
    Bang, Yung-Jue
    Han, Wonshik
    Kim, Woo Ho
    Park, Jae-Gahb
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (06) : 2073 - 2081
  • [10] Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate
    Braeutigam, Karen
    Mitzlaff, Katharina
    Uebel, Lisa
    Koester, Frank
    Polack, Stephan
    Pervan, Mascha
    Steinert, Gunnar
    Rody, Achim
    Liedtke, Cornelia
    ANTICANCER RESEARCH, 2016, 36 (06) : 2759 - 2766
12345